Mei-Ching Liu
Koo Foundation Sun Yat-Sen Cancer Center(TW)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Colorectal Cancer Screening and Detection, Colorectal Cancer Surgical Treatments, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Adjuvant Trastuzumab in HER2-Positive Breast Cancer(2011)2,750 cited
- → Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial(2011)2,312 cited
- → Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial(2018)986 cited
- → 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial(2016)852 cited
- → The Global Breast Cancer Burden: Variations in Epidemiology and Survival(2005)582 cited
- → Interpretation of Magnetic Resonance Imaging for Locally Advanced Rectal Carcinoma After Preoperative Chemoradiation Therapy(2004)176 cited
- → Is Final TNM Staging A Predictor for Survival in Locally Advanced Rectal Cancer after Preoperative Chemoradiation Therapy?(2007)168 cited
- → Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer(2017)125 cited
- → Locoregional failure of postmastectomy patients with 1–3 positive axillary lymph nodes without adjuvant radiotherapy(2002)73 cited
- → How aggressive should we be in patients with stage iv colorectal cancer?(2003)57 cited